A move towards a higher bioavailability of phytocannabinoids
Dr Boštjan Jancar, CTO and head of R&D at PharmaHemp, explains the new products within phytocannabinoids, the differences between its liquid form and powder form, and how the...
Add-on treatment with a hands-on approach
Dr David Neubauer of the Children’s Hospital at University Medical Centre, and of the Medical Faculty at University of Ljubljana, Slovenia, in collaboration with PharmaHemp, discusses...
